Skip to content
stoqly

American Well Corp

AMWL NYSE Services-Business Services, Nec Financials FY2018–FY2025

Revenue Total sales reported in the income statement.
$249M
2.0% vs prior year
Operating margin Operating income as a share of revenue.
βˆ’42.2%
43.3 pts
Net income Profit after all expenses, interest and tax.
βˆ’$95.7M
Free cash flow Cash from operations minus capital spending.
βˆ’$66.0M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
β€”
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On βˆ’$4.78 EPS (TTM)

What American Well Corp does

No business description yet.

Legal name
American Well Corp
Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Feb 12, 2026
Accession Β· CIK
0001193125-26-048776
0001393584

Revenue and margins

American Well Corp had $249M of revenue in fiscal 2025, down 2.0% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was βˆ’$66.0M in fiscal 2025, βˆ’26.5% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

American Well Corp returned β€” to shareholders in fiscal 2025. The diluted share count rose 7.0%.

Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably American Well Corp can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $746M$539M$372M$228M$182M
Current ratio 5.8x5.5x4.8x2.8x3.4x
Quick ratio 5.8x5.4x4.7x2.8x3.4x
Total assets $1.4B$1.2B$590M$436M$324M
Total liabilities $185M$134M$110M$120M$76.0M
Shareholders' equity $1.2B$1.1B$464M$305M$236M
Net debt (βˆ’ = net cash) β€”β€”β€”β€”β€”

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ•
Cash from operations is positive βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ•
Return on assets rose β€” β€” βœ“ βœ“ βœ• βœ• βœ“ βœ“
Cash from operations exceeds net income βœ• βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Debt fell relative to assets β€” β€” β€” β€” β€” β€” β€” β€”
Current ratio rose β€” β€” βœ“ βœ• βœ• βœ• βœ• βœ“
Share count didn't rise β€” βœ• βœ• βœ• βœ“ βœ• βœ• βœ•
Gross margin rose β€” β€” β€” β€” β€” β€” β€” β€”
Revenue rose relative to assets β€” β€” βœ• βœ• βœ“ βœ“ βœ“ βœ“
F-score β€” / 3β€” / 43 / 72 / 73 / 72 / 73 / 74 / 7
Accruals ratio β€”βˆ’1.1%βˆ’11.9%βˆ’2.5%βˆ’5.9%βˆ’58.3%βˆ’15.8%βˆ’7.8%
Altman Z'' β€”βˆ’4.6512.097.486.70βˆ’9.20βˆ’12.29βˆ’16.17

8 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $114M $149M $245M $253M $277M $259M $254M $249M
Net interest income β€” β€” β€” β€” $5.0M $9.3M $11.8M $5.2M
Research and development $36.3M $53.9M $84.4M $107M $138M $106M $86.1M $72.9M
Operating income βˆ’$55.1M βˆ’$94.7M βˆ’$227M βˆ’$179M βˆ’$276M βˆ’$692M βˆ’$218M βˆ’$105M
Pretax income βˆ’$52.3M βˆ’$89.2M βˆ’$226M βˆ’$179M βˆ’$270M βˆ’$675M βˆ’$210M βˆ’$94.5M
Income tax $0.0M βˆ’$0.8M $0.6M βˆ’$5.4M $0.1M $3.9M $2.8M $0.4M
Net income βˆ’$52.7M βˆ’$87.2M βˆ’$224M βˆ’$176M βˆ’$270M βˆ’$675M βˆ’$208M βˆ’$95.7M
Diluted EPS βˆ’$1.30 βˆ’$2.12 βˆ’$2.27 βˆ’$0.69 βˆ’$19.72 βˆ’$47.50 βˆ’$13.88 βˆ’$5.96
Diluted shares 0.04B 0.04B 0.10B 0.25B 0.01B 0.01B 0.01B 0.02B
Cash flow
Cash from operations βˆ’$74.0M βˆ’$81.9M βˆ’$112M βˆ’$142M βˆ’$192M βˆ’$148M βˆ’$127M βˆ’$66.0M
Capital expenditure $1.9M $1.3M $3.3M $0.6M $0.3M $0.2M $0.1M $0.0M
Free cash flow βˆ’$75.9M βˆ’$83.2M βˆ’$116M βˆ’$142M βˆ’$193M βˆ’$149M βˆ’$127M βˆ’$66.0M
Depreciation and amortization $5.3M $7.8M $10.2M $16.1M $26.2M $31.5M $33.0M $34.0M
Stock-based compensation $7.7M $12.1M $118M $43.8M $67.7M $72.2M $47.5M $22.0M
Acquisitions $64.4M $45.8M β€” $157M β€” β€” β€” β€”
Balance sheet
Cash and short-term investments $48.0M $178M $1.0B $746M $539M $372M $228M $182M
Current assets β€” $224M $1.1B $827M $627M $450M $317M $247M
Current liabilities β€” $107M $121M $142M $114M $93.8M $111M $73.2M
Inventory β€” $3.1M $9.1M $7.5M $8.7M $6.7M $2.9M $1.2M
Property and equipment, net β€” $2.7M $3.8M $2.2M $1.0M $0.6M $0.4M $0.2M
Goodwill $127M $194M $194M $443M $435M $0.0M $0.0M β€”
Intangible assets β€” $63.5M $55.5M $152M $135M $120M $102M $66.1M
Total assets β€” $500M $1.4B $1.4B $1.2B $590M $436M $324M
Total liabilities β€” $125M $130M $185M $134M $110M $120M $76.0M
Shareholders' equity βˆ’$204M βˆ’$307M $1.2B $1.2B $1.1B $464M $305M $236M
Margins
Operating margin βˆ’48.4% βˆ’63.6% βˆ’92.7% βˆ’70.9% βˆ’99.5% βˆ’267.2% βˆ’85.5% βˆ’42.2%
EBITDA margin βˆ’43.7% βˆ’58.4% βˆ’88.6% βˆ’64.5% βˆ’90.1% βˆ’255.0% βˆ’72.6% βˆ’28.6%
Net margin βˆ’46.2% βˆ’58.6% βˆ’91.5% βˆ’69.8% βˆ’97.6% βˆ’260.6% βˆ’81.8% βˆ’38.4%
FCF margin βˆ’66.6% βˆ’55.9% βˆ’47.2% βˆ’56.2% βˆ’69.5% βˆ’57.3% βˆ’50.1% βˆ’26.5%
Net interest share of revenue β€” β€” β€” β€” 1.8% 3.6% 4.6% 2.1%
Returns
Return on capital employed β€” βˆ’24.1% βˆ’18.1% βˆ’13.7% βˆ’25.0% βˆ’139.6% βˆ’67.0% βˆ’42.0%
Return on equity β€” β€” βˆ’48.9% βˆ’14.3% βˆ’23.5% βˆ’88.4% βˆ’54.1% βˆ’35.4%
Return on assets β€” βˆ’17.4% βˆ’23.9% βˆ’12.5% βˆ’20.3% βˆ’74.7% βˆ’40.6% βˆ’25.2%
Return on tangible equity β€” β€” βˆ’23.0% βˆ’27.4% βˆ’54.8% βˆ’196.3% βˆ’102.4% βˆ’56.5%
Growth
Revenue growth β€” 30.6% 64.8% 3.1% 9.7% βˆ’6.5% βˆ’1.8% βˆ’2.0%
Share count change β€” 1.4% 140.8% 156.5% βˆ’94.6% 3.6% 5.5% 7.0%
Financial health
Current ratio β€” 2.1x 9.2x 5.8x 5.5x 4.8x 2.8x 3.4x
Quick ratio β€” 2.1x 9.1x 5.8x 5.4x 4.7x 2.8x 3.4x
Capital allocation
Capex / revenue 1.7% 0.9% 1.4% 0.2% 0.1% 0.1% 0.0% 0.0%
Stock comp / revenue 6.7% 8.2% 48.3% 17.3% 24.4% 27.9% 18.7% 8.8%
Quality scores
Piotroski F-score β€” β€” 3.0 2.0 3.0 2.0 3.0 4.0
Altman Z'' β€” βˆ’4.7 12.1 7.5 6.7 βˆ’9.2 βˆ’12.3 βˆ’16.2
Accruals ratio β€” βˆ’1.1% βˆ’11.9% βˆ’2.5% βˆ’5.9% βˆ’58.3% βˆ’15.8% βˆ’7.8%

Source: SEC EDGAR XBRL filings (CIK 0001393584). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open